Synthetic Lethal Interaction of Combined BCL-XL and MEK Inhibition Promotes Tumor Regressions in KRAS Mutant Cancer Models
Cancer Cell - United States
doi 10.1016/j.ccr.2012.11.007
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2013
Authors
Publisher
Elsevier BV